{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:28:59Z","timestamp":1761175739390,"version":"build-2065373602"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-24789-4","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:44:19Z","timestamp":1761119059000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhancing Hepatitis B and C Prevention Among People Who Use Drugs: Evaluating an Educational Intervention at a Drop-In Center in Southwest Iran based on Protection Motivation Theory"],"prefix":"10.1186","volume":"25","author":[{"given":"Tayebeh","family":"Rakhshani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siavash","family":"Chalesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Arman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira","family":"Taravatmanesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Khani","family":"Jeihooni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"24789_CR1","doi-asserted-by":"publisher","unstructured":"Majee, Wilson & David, Ifeolu & Onyeaka, Kelechi. (2025) Youth substance use and addiction: an African perspective toward better quality of life. 10.1007\/978-3-031-65873-0_31. https:\/\/doi.org\/10.1007\/978-3-031-65873-0_31","DOI":"10.1007\/978-3-031-65873-0_31"},{"key":"24789_CR2","doi-asserted-by":"publisher","first-page":"102985","DOI":"10.1016\/j.eclinm.2024.102985","volume":"79","author":"S Kim","year":"2025","unstructured":"Kim S, Lee H, Woo S, Lee H, Park J, Kim T, et al. Global, regional, and national trends in drug use disorder mortality rates across 73 countries from 1990 to 2021, with projections up to 2040: a global time-series analysis and modelling study. EClinicalMedicine. 2025;79:102985. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102985","journal-title":"EClinicalMedicine"},{"issue":"6","key":"24789_CR3","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1080\/10826084.2017.1392981","volume":"53","author":"A Amirabadizadeh","year":"2018","unstructured":"Amirabadizadeh A, Nezami H, Vaughn MG, Nakhaee S, Mehrpour O. Identifying risk factors for drug use in an Iranian treatment sample: a prediction approach using decision trees. Subst Use Misuse. 2018;53(6):1030\u201340. https:\/\/doi.org\/10.1080\/10826084.2017.1392981","journal-title":"Subst Use Misuse"},{"key":"24789_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13011-019-0196-3","volume":"14","author":"D Soroosh","year":"2019","unstructured":"Soroosh D, Neamatshahi M, Zarmehri B, Nakhaee S, Mehrpour O. Drug-induced prolonged corrected QT interval in patients with methadone and opium overdose. Subst Abuse Treat Prev Policy. 2019;14:1\u20135.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"4","key":"24789_CR5","doi-asserted-by":"publisher","first-page":"e21765","DOI":"10.5812\/ijhrba.21765","volume":"3","author":"S Eskandarieh","year":"2014","unstructured":"Eskandarieh S, Jafari F, Yazdani S, Hazrati N, Saberi-Zafarghandi MB. Compulsory maintenance treatment program amongst Iranian injection drug users and its side effects. Int J High Risk Behav Addict. 2014;3(4):e21765.","journal-title":"Int J High Risk Behav Addict"},{"issue":"2","key":"24789_CR6","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDra2200292","volume":"2","author":"KM Rich","year":"2023","unstructured":"Rich KM, Solomon DA. Medical complications of injection drug use - Part I. NEJM Evid. 2023;2(2):EVIDra2200292.","journal-title":"NEJM Evid"},{"key":"24789_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(24)00442-4","author":"A Artenie","year":"2025","unstructured":"Artenie A, Trickey A, Looker KJ, Stone J, Lim AG, Fraser H, et al. Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: a multi-stage analysis. Lancet Gastroenterol Hepatol. 2025. https:\/\/doi.org\/10.1016\/S2468-1253(24)00442-4.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"24789_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107293","volume":"150","author":"L Huang","year":"2025","unstructured":"Huang L, Chen X, Wang Z. Total burden of hepatitis B and C attributed to injecting drug use in 204 countries and territories from 1990 to 2021: analyses based on the global burden of disease study 2021. Int J Infect Dis. 2025;150:107293.","journal-title":"Int J Infect Dis"},{"key":"24789_CR9","doi-asserted-by":"publisher","unstructured":"Uribe-Noguez LA, Prieto-Torres ME, Uribe-Noguez LO, Mata-Mar\u00edn JA, Arroyo-Anduiza CI, Paquent\u00edn-Jimenez R, Chaparro-Sanchez A, Vazquez-Gonzalez WG, Santos Coy-Arechavaleta A, Pompa-Mera EN et al. Prevalence and risk factors of occult HCV infection in the adult population of Mexico City. Viruses. 2025; 17(2). https:\/\/doi.org\/10.3390\/v17020236","DOI":"10.3390\/v17020236"},{"issue":"1","key":"24789_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cger.2013.10.012","volume":"30","author":"AT Duddempudi","year":"2014","unstructured":"Duddempudi AT, Bernstein DE. Hepatitis B and C. Clin Geriatr Med. 2014;30(1):149\u201367.","journal-title":"Clin Geriatr Med"},{"issue":"1","key":"24789_CR11","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1186\/s12889-020-09292-2","volume":"20","author":"C Liu","year":"2020","unstructured":"Liu C, Nicholas S, Wang J. The association between protection motivation and hepatitis b vaccination intention among migrant workers in tianjin, china: a cross-sectional study. BMC Public Health. 2020;20(1):1219.","journal-title":"BMC Public Health"},{"issue":"1","key":"24789_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.32598\/CJHR.8.1.470.1","volume":"8","author":"S Zhalegholi","year":"2023","unstructured":"Zhalegholi S, Kasmaei P, Bakhshi F, Fattahi E, Jadgal MS, Mehrabian F, Rouhani-Tonekaboni N. The application of protection motivation theory in predicting AIDS prevention behaviors in drug addicts living in addiction treatment camps. Casp J Health Res. 2023;8(1):45\u201352.","journal-title":"Casp J Health Res"},{"issue":"1","key":"24789_CR13","doi-asserted-by":"publisher","first-page":"2442026","DOI":"10.1080\/02673843.2024.2442026","volume":"30","author":"T Rakhshani","year":"2025","unstructured":"Rakhshani T, Sajedeh K, Amirhossein K, Asiyeh Y, Khani Jeihooni A. The effect of an educational intervention in prevention of drug abuse in students. Int J Adolescence Youth. 2025;30(1):2442026.","journal-title":"Int J Adolescence Youth"},{"issue":"1","key":"24789_CR14","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1186\/s12889-024-18092-x","volume":"24","author":"T Olaoye","year":"2024","unstructured":"Olaoye T, Osie-Efietie B, Ogunsanmi OO, Mustapha AM, Asekun-Olarinmoye I, Atulomah NO. Evaluation of a school-based health education program on hepatitis B virus infection prevention practice in rural South-Western, Nigeria. BMC Public Health. 2024;24(1):591.","journal-title":"BMC Public Health"},{"key":"24789_CR15","doi-asserted-by":"publisher","DOI":"10.5114\/hivar.2023.124680","author":"MS Jadgal","year":"2023","unstructured":"Jadgal MS, Heshmati H, Keshavarz M, Zareipour M, Faryabi R, Alizadeh-Siuki H. Effect of theory of planned behavior-based educational intervention on HIV\/AIDS preventive behaviors among male barbers. HIV AIDS Rev. 2023. https:\/\/doi.org\/10.5114\/hivar.2023.124680.","journal-title":"HIV AIDS Rev"},{"issue":"8","key":"24789_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100777","volume":"5","author":"PC Matthews","year":"2023","unstructured":"Matthews PC, Ocama P, Wang S, El-Sayed M, Turkova A, Ford D, et al. Enhancing interventions for prevention of mother-to-child- transmission of hepatitis B virus. JHEP Rep. 2023;5(8):100777.","journal-title":"JHEP Rep"},{"key":"24789_CR17","doi-asserted-by":"publisher","first-page":"1122048","DOI":"10.3389\/fimmu.2023.1122048","volume":"14","author":"H Lu","year":"2023","unstructured":"Lu H, Cao W, Zhang L, Yang L, Bi X, Lin Y, Deng W, Jiang T, Sun F, Zeng Z, et al. Effects of hepatitis B virus infection and strategies for preventing mother-to-child transmission on maternal and fetal T-cell immunity. Front Immunol. 2023;14:1122048.","journal-title":"Front Immunol"},{"issue":"1","key":"24789_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/17437199.2024.2413011","volume":"19","author":"J Balla","year":"2025","unstructured":"Balla J, Hagger MS. Protection motivation theory and health behaviour: conceptual review, discussion of limitations, and recommendations for best practice and future research. Health Psychol Rev. 2025;19(1):145\u201371.","journal-title":"Health Psychol Rev"},{"issue":"4","key":"24789_CR19","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1460-2466.2001.tb02900.x","volume":"51","author":"RN Rimal","year":"2006","unstructured":"Rimal RN. Perceived risk and Self-Efficacy as motivators: Understanding individuals\u2019 Long-Term use of health information. J Communication. 2006;51(4):633\u201354.","journal-title":"J Communication"},{"issue":"1","key":"24789_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1559-1816.2000.tb02308.x","volume":"30","author":"S MILNE","year":"2000","unstructured":"MILNE S, SHEERAN P. Prediction and intervention in Health-Related behavior: A Meta-Analytic review of protection motivation theory. J Appl Soc Psychol. 2000;30(1):106\u201343.","journal-title":"J Appl Soc Psychol"},{"key":"24789_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/jpepsy\/jsi001","volume":"30","author":"Y Wu","year":"2005","unstructured":"Wu Y, Stanton B, Li X, Galbraith J, Cole M. Protection motivation theory and adolescent drug trafficking: relationship between health motivation and longitudinal risk involvement. J Pediatr Psychol. 2005;30:127\u201337.","journal-title":"J Pediatr Psychol"},{"issue":"3","key":"24789_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/ADM.0000000000000112","volume":"9","author":"A Salehi","year":"2015","unstructured":"Salehi A, Naghshvarian M, Marzban M, Bagheri Lankarani K. Prevalence of HIV, HCV, and High-Risk behaviors for substance users in drop in centers in Southern Iran. J Addict Med. 2015;9(3):181\u20137.","journal-title":"J Addict Med"},{"issue":"7","key":"24789_CR23","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1111\/add.14905","volume":"115","author":"H Ekhtiari","year":"2020","unstructured":"Ekhtiari H, Noroozi A, Farhoudian A, Radfar SR, Hajebi A, Sefatian S, Zare-Bidoky M, Razaghi EM, Mokri A, Rahimi-Movaghar A, et al. The evolution of addiction treatment and harm reduction programs in iran: a chaotic response or a synergistic diversity? Addiction. 2020;115(7):1395\u2013403.","journal-title":"Addiction"},{"issue":"2","key":"24789_CR24","first-page":"118","volume":"1","author":"M Tavakol","year":"2016","unstructured":"Tavakol M, Naserirad M, Avanessian E, Anis S, Abrahamian H. Differential quality assessment of harm reduction service in Drop-in centers and shelters: from expectations to perceptions. J Health Lit. 2016;1(2):118\u201328.","journal-title":"J Health Lit"},{"issue":"3","key":"24789_CR25","first-page":"623","volume":"79","author":"H Mokhayeri","year":"2024","unstructured":"Mokhayeri H, Hasanvand B, Birjandi M, Mirzaei H, sasaei P, Zamani S, bajlan S, Akbari A, Khanizadeh S. Prevalence of HIV, HBV, and HCV infections and high-risk behaviors among women referred to drop-in centers of Lorestan province, Western Iran. Arch Razi Inst. 2024;79(3):623\u20138.","journal-title":"Arch Razi Inst"},{"issue":"1","key":"24789_CR26","doi-asserted-by":"publisher","first-page":"e0003284","DOI":"10.1371\/journal.pgph.0003284","volume":"5","author":"HN Manley","year":"2025","unstructured":"Manley HN, Riback LR, Nyakowa M, Akiyama MJ, Cherutich P, Lizcano J, Kurth A, Muller A. Barriers to and impacts of hepatitis C treatment among people who inject drugs in kenya: A qualitative study. PLOS Global Public Health. 2025;5(1):e0003284.","journal-title":"PLOS Global Public Health"},{"key":"24789_CR27","doi-asserted-by":"publisher","first-page":"103100","DOI":"10.1016\/j.pmedr.2025.103100","volume":"54","author":"F Elamouri","year":"2025","unstructured":"Elamouri F, Rockstroh JK, Teetipsatit S, Mohamedkhair SG, Pumpaibool T. Effects of loving or HABIBI educational prevention intervention on HIV\/AIDS knowledge, attitude and condom use among internally displaced males from libya: A quasi-experimental study. Prev Med Rep. 2025;54:103100.","journal-title":"Prev Med Rep"},{"key":"24789_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.103040","author":"M Makhoul","year":"2025","unstructured":"Makhoul M, Mumtaz GR, Ayoub HH, Jamil MS, Hermez JG, Alaama AS, et al. Hepatitis C virus transmission among people who inject drugs in the Middle East and North Africa: mathematical modeling analyses of incidence and intervention impact. eClinicalMedicine. 2025. https:\/\/doi.org\/10.1016\/j.eclinm.2024.103040.","journal-title":"eClinicalMedicine"},{"key":"24789_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21859\/jech.5.2.1","volume":"5","author":"M eftekhari","year":"2018","unstructured":"eftekhari M, Peyman N. Effect of educational intervention based on protection motivation theory on promoting pediculosis preventive behaviors among elementary school girls in Neyshabur. J Educ Community Health. 2018;5:1\u20137.","journal-title":"J Educ Community Health"},{"issue":"3","key":"24789_CR30","doi-asserted-by":"publisher","first-page":"264","DOI":"10.4103\/ijnmr.ijnmr_275_21","volume":"28","author":"WT Elgzar","year":"2023","unstructured":"Elgzar WT, Sayed SH, Hussien NK, Allam TH. The effect of an educational intervention based on protection motivation theory on pregnant women\u2019s knowledge and Self-Protection regarding COVID-19. An intervention study. Iran J Nurs Midwifery Res. 2023;28(3):264\u201372.","journal-title":"Iran J Nurs Midwifery Res"},{"issue":"4","key":"24789_CR31","first-page":"171","volume":"10","author":"SS Hosseini Zijoud","year":"2023","unstructured":"Hosseini Zijoud SS, Rahaei Z, Hekmatimoghaddam S, Zarei S, Sadeghian HA. Effect of education based on the protection motivation theory on the promotion of protective behaviors in medical laboratories\u2019 staff in yazd, Iran. Int Archives Health Sci. 2023;10(4):171\u20136.","journal-title":"Int Archives Health Sci"},{"issue":"1","key":"24789_CR32","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12905-025-03680-9","volume":"25","author":"Z Japalaghi","year":"2025","unstructured":"Japalaghi Z, Bahrami A, Beiranvand R, Soltaninejad H, Varseh M, Sharifi N. The effect of educational intervention based on protection motivation theory in improving reproductive health protective behaviors: a quasi-experimental study. BMC Womens Health. 2025;25(1):154.","journal-title":"BMC Womens Health"},{"key":"24789_CR33","doi-asserted-by":"publisher","first-page":"102992","DOI":"10.1016\/j.drugpo.2020.102992","volume":"87","author":"P Roux","year":"2021","unstructured":"Roux P, Donadille C, Magen C, Schatz E, Stranz R, Curado A, Tsiakou T, Verdes L, Aleksova A, Carrieri P, et al. Implementation and evaluation of an educational intervention for safer injection in people who inject drugs in europe: a multi-country mixed-methods study. Int J Drug Policy. 2021;87:102992.","journal-title":"Int J Drug Policy"},{"key":"24789_CR34","doi-asserted-by":"publisher","first-page":"103588","DOI":"10.1016\/j.drugpo.2022.103588","volume":"102","author":"T Schwarz","year":"2022","unstructured":"Schwarz T, Horv\u00e1th I, Fenz L, Schmutterer I, Rosian-Schikuta I, M\u00e5rdh O. Interventions to increase linkage to care and adherence to treatment for hepatitis C among people who inject drugs: A systematic review and practical considerations from an expert panel consultation. Int J Drug Policy. 2022;102:103588.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"24789_CR35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s43045-024-00432-7","volume":"31","author":"E Sharifi","year":"2024","unstructured":"Sharifi E, Ghelbash Z, Karami A, Musarezaie A. Effects of a comprehensive educational program on health behaviors and awareness of HIV, hepatitis B, and hepatitis C in men with substance use disorders. Middle East Curr Psychiatry. 2024;31(1):43.","journal-title":"Middle East Curr Psychiatry"},{"issue":"11","key":"24789_CR36","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.addbeh.2011.06.010","volume":"36","author":"EE Bonar","year":"2011","unstructured":"Bonar EE, Rosenberg H. Using the health belief model to predict injecting drug users\u2019 intentions to employ harm reduction strategies. Addict Behav. 2011;36(11):1038\u201344.","journal-title":"Addict Behav"},{"key":"24789_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2025.104720","volume":"137","author":"A Stevens","year":"2025","unstructured":"Stevens A, Lafferty L, Treloar C, Cunningham EB, Dore GJ, Grebely J, et al. Acceptability of hepatitis C testing using point-of-care testing and dried blood spot collection among people at risk of hepatitis C infection. Int J Drug Policy. 2025;137:104720.","journal-title":"Int J Drug Policy"},{"key":"24789_CR38","doi-asserted-by":"publisher","first-page":"111384","DOI":"10.1016\/j.drugalcdep.2024.111384","volume":"262","author":"SS Lopes","year":"2024","unstructured":"Lopes SS, Pericot-Valverde I, Dotherow JE, Lum PJ, Taylor LE, Mehta SH, Tsui JI, Feinberg J, Kim AY, Norton BL, et al. Effect of self-efficacy among persons who inject drugs treated with direct-acting antivirals on hepatitis C treatment initiation, duration, completion, adherence, and cure. Drug Alcohol Depend. 2024;262:111384.","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"24789_CR39","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1007\/s10461-024-04433-9","volume":"28","author":"K Bailey","year":"2024","unstructured":"Bailey K, Abramovitz D, Rangel G, Harvey-Vera A, Vera CF, Patterson TL, S\u00e1nchez-Lira JA, Davidson PJ, Garfein RS, Smith LR, et al. Safe injection Self-Efficacy is associated with HCV and HIV seropositivity among people who inject drugs in the San Diego-Tijuana border region. AIDS Behav. 2024;28(11):3629\u201342.","journal-title":"AIDS Behav"},{"issue":"4","key":"24789_CR40","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1080\/09540121.2023.2208318","volume":"36","author":"P K\u00fcnzler-Heule","year":"2024","unstructured":"K\u00fcnzler-Heule P, Schmidt AJ, Fierz K, Battegay M, Engberg S, Kouyos RD, N\u00f6stlinger C, St\u00f6ckle M, B\u00e9guelin C, Delaloye J, et al. Exploring group differences in the response to a sexual risk reduction intervention to prevent hepatitis C virus reinfection in HIV-infected MSM: a mixed-methods study. AIDS Care. 2024;36(4):442\u201351.","journal-title":"AIDS Care"},{"issue":"2","key":"24789_CR41","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.socscimed.2007.08.022","volume":"66","author":"J Cox","year":"2008","unstructured":"Cox J, De P, Morissette C, Tremblay C, Stephenson R, Allard R, Graves L, Roy E. Low perceived benefits and self-efficacy are associated with hepatitis C virus (HCV) infection-related risk among injection drug users. Soc Sci Med. 2008;66(2):211\u201320.","journal-title":"Soc Sci Med"},{"key":"24789_CR42","doi-asserted-by":"publisher","first-page":"103247","DOI":"10.1016\/j.drugpo.2021.103247","volume":"96","author":"A Amoako","year":"2021","unstructured":"Amoako A, Ortiz-Paredes D, Engler K, Lebouch\u00e9 B, Klein MB. Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis. Int J Drug Policy. 2021;96:103247.","journal-title":"Int J Drug Policy"},{"key":"24789_CR43","doi-asserted-by":"publisher","first-page":"205032452311991","DOI":"10.1177\/20503245231199163","volume":"9","author":"Z Belrhiti","year":"2023","unstructured":"Belrhiti Z, Serghini FZ. Perceived barriers to access to hepatitis C for people who inject drugs in morocco: A qualitative explorative study. Drug Sci Policy Law. 2023;9:20503245231199163.","journal-title":"Drug Sci Policy Law"},{"issue":"1","key":"24789_CR44","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12954-020-00409-9","volume":"17","author":"JE Sherbuk","year":"2020","unstructured":"Sherbuk JE, Tabackman A, McManus KA, Kemp Knick T, Schexnayder J, Flickinger TE, Dillingham R. A qualitative study of perceived barriers to hepatitis C care among people who did not attend appointments in the non-urban US South. Harm Reduct J. 2020;17(1):64.","journal-title":"Harm Reduct J"},{"issue":"1","key":"24789_CR45","doi-asserted-by":"publisher","first-page":"4660336","DOI":"10.1155\/2024\/4660336","volume":"2024","author":"A Khani Jeihooni","year":"2024","unstructured":"Khani Jeihooni A, Mohammadkhah F, Bijani M, Harsini PA. Changing the High-Risk behaviors of injecting drug users in iran: application theory of planned behavior. Sci World J. 2024;2024(1):4660336.","journal-title":"Sci World J"},{"issue":"2","key":"24789_CR46","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/08964289.2022.2142501","volume":"50","author":"A Malaguti","year":"2024","unstructured":"Malaguti A, Byrne CJ, Sani F, Power K, Eriksen A, Dillon JF. Drug network identification predicts injecting risk behavior among people who inject drugs on hepatitis C virus treatment in tayside, Scotland. Behav Med. 2024;50(2):130\u201340.","journal-title":"Behav Med"},{"key":"24789_CR47","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.drugpo.2017.05.041","volume":"47","author":"TI Mukherjee","year":"2017","unstructured":"Mukherjee TI, Pillai V, Ali SH, Altice FL, Kamarulzaman A, Wickersham JA. Evaluation of a hepatitis C education intervention with clients enrolled in methadone maintenance and needle\/syringe programs in Malaysia. Int J Drug Policy. 2017;47:144\u201352.","journal-title":"Int J Drug Policy"},{"key":"24789_CR48","doi-asserted-by":"publisher","first-page":"102983","DOI":"10.1016\/j.drugpo.2020.102983","volume":"87","author":"S Goutzamanis","year":"2021","unstructured":"Goutzamanis S, Doyle JS, Horyniak D, Higgs P, Hellard M. Peer to peer communication about hepatitis C treatment amongst people who inject drugs: A longitudinal qualitative study. Int J Drug Policy. 2021;87:102983.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"24789_CR49","first-page":"513","volume":"5","author":"M Uzair Khalid","year":"2022","unstructured":"Uzair Khalid M, Khan S, Koerber D, Ashok Shah H. Educational interventions to improve hepatitis C testing or treatment in South Asian communities: A systematic review. Can Liver J. 2022;5(4):513\u201329.","journal-title":"Can Liver J"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-24789-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-24789-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-24789-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:06:31Z","timestamp":1761123991000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-24789-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24789"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-24789-4","relation":{},"ISSN":["1471-2458"],"issn-type":[{"type":"electronic","value":"1471-2458"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"8 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study procedures were carried out following the Declaration of Helsinki. This study was approved by the Ethics Committee of Shiraz University of Medical Sciences. Informed consent was taken from all the participants. Informed consent was taken from all the participants. For illiterate people, informed consent from a parent and\/or legal guardian was obtained in the study. There was an emphasis on maintaining privacy in keeping and delivering the information accurately without mentioning the names of the participants. The participants were given the right to leave the interview at any time if they wished to leave the interview process, and they were promised to have the study results if they want.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3565"}}